Sigachi Industries has received Terms of Reference (ToR) from the State Environment Impact Assessment Authority (SEIAA), Andhra Pradesh, for its upcoming Bulk Drugs, Drug Intermediates, and Specialty Chemicals facility at Orvakal, Kurnool District.
The project is proposed on 25.09 acres at Guttapadu-Orvakal Node and falls under Category B1 of the EIA Notification, 2006.
Environmental Clearance (EC) process will commence from 15th July 2025, with project development activities starting from 1st August 2025.
The project aims to enhance API manufacturing capacity, support pipeline expansion, establish a strategically located facility with export potential, and contribute to 'Make in India'.
Mr. Amit Raj Sinha, MD and CEO of Sigachi Industries, stated that this is a significant milestone to become a vertically integrated pharmaceutical manufacturing company and will help create scalable, sustainable, and compliant operations for global markets. He also mentioned that the facility will strengthen the product supply chain and enable faster commercialization.